WVXU: How re-engineering HIV patient's blood may lead to a cure
Researchers at UC are collaborating in a study that will pinpoint and alter a specific gene in people with HIV. The hope is that process will lower the amount of HIV in the person’s body, and could possibly lead to the development of a cure for HIV.
WVXU interviewed Carl Fichtenbaum of the Division of Infectious Diseases at the UC College of Medicine about the TRAILBLAZER study which will target and modify the C-C motif chemokine receptor (CCR5) gene, creating a mutation that prohibits the entry of HIV into specific white blood cells called lymphocytes.
Additional Contacts
Related Stories
University of Cincinnati celebrates DAAP's class of 2024:...
April 27, 2024
Discover the achievements of the University of Cincinnati's College of Design, Architecture, Art, and Planning's Class of 2024 as they graduate into the alumni family, showcasing exceptional talent and innovation. From prestigious awards to prominent job offers, these graduates exemplify the transformative power of creativity and dedication in shaping tomorrow's leaders.
Ancient Maya blessed their ballcourts
April 26, 2024
Using environmental DNA analysis, researchers identified a collection of plants used in ceremonial rituals in the ancient Maya city of Yaxnohcah. The plants, known for their religious associations and medicinal properties, were discovered beneath a plaza floor upon which a ballcourt was built, suggesting the building might have been blessed or consecrated during construction.
UC celebrates record graduating class at commencement
April 26, 2024
UC celebrated its doctoral hooding and master's recognition ceremony at Fifth Third Arena as part of its three-day commencement for the largest graduating class in university history.